Anti-Tumor Activity of Glutaminase Inhibitor CB-839 in Solid Tumor Malignancies

On January 1, 2018 Calithera Biosciences presented the corporate presentation (Presentation, Calithera Biosciences, JAN 1, 2018, View Source [SID1234535270]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!


Daiichi Sankyo Cancer Enterprise

On January 1, 2018 Daiichi Sankyo presents "Daiichi Sankyo Cancer Enterprise" presentation (Presentation, Daiichi Sankyo, JAN 1, 2018, View Source [SID1234525225]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Corporate Presentation

On January 1, 2018 Juno presented Corporate Presentation (Presentation, Juno, JAN 1, 2018, View Source [SID1234523901]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!